CN1953669B - β-隐黄质的用途 - Google Patents

β-隐黄质的用途 Download PDF

Info

Publication number
CN1953669B
CN1953669B CN2005800158315A CN200580015831A CN1953669B CN 1953669 B CN1953669 B CN 1953669B CN 2005800158315 A CN2005800158315 A CN 2005800158315A CN 200580015831 A CN200580015831 A CN 200580015831A CN 1953669 B CN1953669 B CN 1953669B
Authority
CN
China
Prior art keywords
cryptoxanthin
purposes
beta
composition
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800158315A
Other languages
English (en)
Chinese (zh)
Other versions
CN1953669A (zh
Inventor
安妮·埃辛格
瑞吉纳·古拉尔奇克
卡林·威兹
艾德里安·维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN1953669A publication Critical patent/CN1953669A/zh
Application granted granted Critical
Publication of CN1953669B publication Critical patent/CN1953669B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
CN2005800158315A 2004-05-18 2005-05-10 β-隐黄质的用途 Expired - Fee Related CN1953669B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04011743.4 2004-05-18
EP04.011743.4 2004-05-18
EP04011743 2004-05-18
PCT/EP2005/005030 WO2005110122A1 (en) 2004-05-18 2005-05-10 USE OF β-CRYPTOXANTHIN

Publications (2)

Publication Number Publication Date
CN1953669A CN1953669A (zh) 2007-04-25
CN1953669B true CN1953669B (zh) 2010-06-16

Family

ID=34966671

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800158315A Expired - Fee Related CN1953669B (zh) 2004-05-18 2005-05-10 β-隐黄质的用途

Country Status (9)

Country Link
US (1) US20080070980A1 (enExample)
EP (1) EP1748705B1 (enExample)
JP (2) JP5145035B2 (enExample)
KR (1) KR101317976B1 (enExample)
CN (1) CN1953669B (enExample)
AT (1) ATE484201T1 (enExample)
DE (1) DE602005024128D1 (enExample)
ES (1) ES2351701T3 (enExample)
WO (1) WO2005110122A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008013219A1 (ja) * 2006-07-28 2009-12-17 ユニチカ株式会社 クリプトキサンチンの高吸収性経口投与組成物
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5688697B2 (ja) * 2009-09-25 2015-03-25 国立大学法人愛媛大学 免疫蛋白質の産生促進剤
JP5909084B2 (ja) * 2010-12-15 2016-04-26 アークレイ株式会社 安定化βクリプトキサンチン含有水およびその用途
CN102219721B (zh) * 2011-04-02 2013-08-07 秦皇岛大惠生物技术有限公司 一种含有β-隐黄质的浓缩物的提取方法与采用该方法所得到的浓缩物及其用途
WO2013009378A1 (en) * 2011-07-13 2013-01-17 University Of Georgia Research Foundation, Inc. Use of xanthophyll carotenoids to improve visual performance and neural efficiency
BR112015007131A2 (pt) * 2012-10-04 2017-07-04 Abbott Lab métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética
JP5687682B2 (ja) * 2012-12-20 2015-03-18 ユニチカ株式会社 カルシウム吸収促進組成物
SG11201505759RA (en) 2013-01-24 2015-08-28 Omniactive Health Technologies Ltd Beta-cryptoxanthin from plant source and a process for its preparation
KR20160016926A (ko) * 2013-05-31 2016-02-15 디에스엠 아이피 어셋츠 비.브이. 사료 보충제 및 이의 용도
CN107205439A (zh) * 2015-01-15 2017-09-26 帝斯曼知识产权资产管理有限公司 具有25‑羟基维生素d和抗氧化剂/抗炎剂的组合的家禽饲料
US10568846B2 (en) * 2015-04-27 2020-02-25 Omniactive Health Technologies Limited Betacryptoxanthin compositions, processes for preparation and uses thereof
CN104906112B (zh) * 2015-05-20 2018-02-23 杨克西 一种促进蛋白质合成的组合物及其制备方法和用途
JP2019218316A (ja) * 2018-06-21 2019-12-26 公立大学法人大阪 オートファジー活性向上剤
SG10201900604TA (en) 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
WO2022018162A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. FORMULATIONS OF NEW β-CRYPTOXANTHIN CRYSTAL FORM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USES
WO2022018161A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. Beta-cryptoxanthin crystal forms, liquid formulations thereof and processes for their manufacture
CN115530381A (zh) * 2022-08-17 2022-12-30 中南大学 预防产前抑郁症的蛋白粉及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568364A1 (en) * 2002-10-25 2005-08-31 Kemin Foods L.C. Osteogenesis promoter containing beta-cryptoxanthin as the active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568364A1 (en) * 2002-10-25 2005-08-31 Kemin Foods L.C. Osteogenesis promoter containing beta-cryptoxanthin as the active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Jun Lee etc..Dietary Cryptoxanthin and Reduced Risk of Lung Cancer:Cancer Epidemiology Biomarkers & Prevention.American Association for Cancer Research12 11.2003,12(11),摘要. *

Also Published As

Publication number Publication date
JP2013047227A (ja) 2013-03-07
EP1748705A1 (en) 2007-02-07
DE602005024128D1 (de) 2010-11-25
JP5145035B2 (ja) 2013-02-13
WO2005110122A1 (en) 2005-11-24
US20080070980A1 (en) 2008-03-20
ES2351701T3 (es) 2011-02-09
KR20070011515A (ko) 2007-01-24
CN1953669A (zh) 2007-04-25
EP1748705B1 (en) 2010-10-13
KR101317976B1 (ko) 2013-10-14
ATE484201T1 (de) 2010-10-15
JP2008500376A (ja) 2008-01-10

Similar Documents

Publication Publication Date Title
CN1953669B (zh) β-隐黄质的用途
EP2799083B1 (en) Muscle atrophy inhibitor
JP2005501061A (ja) 免疫機能損傷患者の為の栄養療法
US20120309716A1 (en) Motor Function Improver
US20220387464A1 (en) Inositol phosphate-containing composition
WO2004075905A1 (ja) 筋肉増強剤および筋肉減衰の予防または治療剤
US20090233880A1 (en) Equol production accelerating composition
JP5922862B2 (ja) ミトコンドリア機能向上剤
JP6716330B2 (ja) ウロプラキン発現促進剤
ES2765238T3 (es) Agente promotor de la producción de IGF-1
KR20240088908A (ko) Ampk 활성화제, 운동 기능 향상제, 근지구력 향상제 및 근위축 억제제
WO2023119368A1 (ja) 液体組成物およびサーチュイン活性化用組成物
JP6117963B2 (ja) ポリアミンを有効成分とする、組織の再生を促進するための組成物
JP7729581B2 (ja) 肝機能向上剤および肝機能向上用経口組成物
JP2021024838A (ja) 子における脳由来神経栄養因子の産生を促進させる組成物
JP5674047B2 (ja) コレシストキニン分泌促進剤
JP5022060B2 (ja) インターロイキン−１０産生促進剤
CN120152709A (zh) 使用甘氨酸来降低成年动物的生物学年龄的组合物和方法
JP2011063547A (ja) 無酸素性運動向上剤及び無酸素性運動向上用の食品
JP2004083525A (ja) 抗ウイルス組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100616